European regulators are giving approval to Israel’s ITGI Medical to market the company’s new pericardium covered coronary stent, called AneuGraft®, a device designed specifically for tortuous arteries.
AneuGraft® is a stent 100% covered with a heterologous tissue, designed to set a barrier between the coronary blood vessel wall and its lumen. It is intended for situations in tortuous vessels.
"AneuGraft® Pericardium Covered Stent is especially suitable for patients with tortuous vessels where other covered stents may not be adequate for use due to limitations resulting from tortuous anatomy” says Efri Argaman ITGI Medical CEO.
AneuGraft ® is a unique stent, second in a series of heterologous tissue covered stents, designed to set a barrier between the blood vessel wall and its lumen.
AneuGraft ® PCS is indicated for treatment of bypass stenosis, aneurysms and for emergency situations such as perforations in tortuous vessels.
Press release: ITGI medical received a CE Mark approval for AneuGraft® – Heterologous tissue covered stent for for coronary tortuous vessels… (.pdf)
ITGI coronary stent page…
Flashback: Over and Under Pericardium Covered Stent from ITGI Medical